Hepatology
813 articles · 19 journals
Journals in this subcategory (19)
- Annals of Hepatology · Elsevier (90)
- Journal of Hepatology · Elsevier (80)
- Journal of Hepato-Biliary-Pancreatic Sciences · Wiley (74)
- HPB · Elsevier (72)
- Gastroenterology · Elsevier (64)
- Gastroenterología y Hepatología · Elsevier (63)
- Journal of Clinical and Experimental Hepatology · Elsevier (61)
- Clinics in Liver Disease · Elsevier (48)
- Cellular and Molecular Gastroenterology and Hepatology · Elsevier (45)
- Journal of Liver Transplantation · Elsevier (44)
- Journal of Gastroenterology and Hepatology (Australia) · Wiley (41)
- The Lancet Gastroenterology & Hepatology · Elsevier (37)
- Liver International · Wiley (34)
- Portal Hypertension and Cirrhosis · Wiley (28)
- Liver Research · Elsevier (19)
- Journal of Viral Hepatitis · Wiley (13)
- Current Hepatology Reports · Springer Nature (0)
- Egyptian Liver Journal · Springer Nature (0)
- Hepatology International · Springer Nature (0)
- Pragmatism should not eclipse validation in expanded HBV management for Latin America: response
- Pragmatism should not eclipse validation in expanded HBV management for Latin America
- Comment on “Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes”
- Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”
- Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
- THR-β agonism in MASH: expanding the evidence to Asia
- Updated treatment targets in inflammatory bowel disease (STRIDE-III): an initiative of the International Organization for the Study of IBD
- Baveno VIII: what's new?
- Defining molecular remission in inflammatory bowel disease: lessons from oncology
- Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer
- Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer – Authors’ reply
- Lessons from the TRIPLET-HCC trial
- Lessons from the TRIPLET-HCC trial – Authors’ reply
- The implementation gap in aspirin chemoprevention for Lynch syndrome
- Combination therapy for MASH
- Validation of Rome V for irritable bowel syndrome
- Validation of Rome V for irritable bowel syndrome – Authors’ reply
- Tackling the global liver disease syndemic through primary care in the Asia-Pacific region
- Incidence of inflammatory bowel disease in Jakarta, Indonesia, 2021–24
- Correction to Lancet Gastroenterol Hepatol 2025; 10: 537–49
- Research in Brief
- Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
- On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
- ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial
- Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis
- Pathophysiology of irritable bowel syndrome
- The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence
- Global, regional, and national burden of gallbladder and biliary diseases in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
- Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 48-week results from a multicentre, randomised, double-blind, phase 2b study
- Guinea-Bissau HepB birth-dose vaccine trial: still unethical